{"id":"W4411539937","doi":"10.1007/s13555-025-01452-9","title":"Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)","year":2025,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Queen's University","funders":"Dermira; Eli Lilly and Company","keywords":"Extension (predicate logic); Atopic dermatitis; Term (time); Dermatology; Medicine; Pediatrics; Computer science; Physics; Programming language","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002964496,0.000500619,0.001057894,0.000192306,0.0003207346,0.0005800306,0.0003761049,0.0005828831,0.001637089],"category_scores_gemma":[0.001104167,0.0002294608,0.001724705,0.0002245452,0.0003066586,0.0005935088,0.0003936195,0.001439532,0.0002862006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004023149,"about_ca_system_score_gemma":0.0006541244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004281792,"about_ca_topic_score_gemma":0.001250379,"domain_scores_codex":[0.9993811,0.0002907955,0.00005491039,0.0001012627,0.00007722852,0.0000947336],"domain_scores_gemma":[0.9984653,0.0003444626,0.0004633951,0.0001713976,0.0001427001,0.0004127305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7727292,0.02043678,0.05789016,0.0009209405,0.002033883,0.0002694706,0.0003187034,0.0009776388,0.02170492,0.0001225851,0.00135056,0.1212452],"study_design_scores_gemma":[0.1899498,0.5987035,0.1996428,0.0001097717,0.002507625,0.0004908871,0.00009865304,0.0009270963,0.003992826,0.0001448418,0.003385694,0.00004654243],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99737,0.001509964,0.0001331367,0.00006661896,0.00001885653,0.0002285852,0.0002159018,0.00001238139,0.000444394],"genre_scores_gemma":[0.9976876,0.0004621829,0.0003149975,0.0001663184,0.00005496349,0.0002487193,0.0005536036,0.000003185146,0.0005085418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002964496,"threshold_uncertainty_score":0.01567793,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007114266231606919,"score_gpt":0.254723067199235,"score_spread":0.2476088009676281,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}